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Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan

ABSTRACT
Objective: To assess the clinical outcomes of revascularisation based on fractional ﬂow reserve (FFR) and/or instantaneous
wave-free ratio (iFR).
Study Design: Descriptive study.
Place and Duration of Study: Department of Medicine, The Aga Khan University Hospital, Karachi from January 2012 to
January 2020.
Methodology: A cohort of patients having moderate to severe coronary stenosis, undergoing coronary revascularisation based
on invasive physiological assessment (FFR or iFR) were assessed. The participants were divided into the revascularisation-deferred group and the revascularization-performed group, based on the physiological results. Cox-proportional hazard model
building was done, using a stepwise approach by assessing all plausible interactions and considering p-value ≤0.05 as statistically signiﬁcant.
Results: The frequency of major adverse cardiac event (MACE) and target vessel revascularisation was 8.4% and 3.2% in the
revascularisation-performed group as compared to 6.4% and 3.2% in the revascularisation-deferred group. In adjusted models,
no statistically signiﬁcant diﬀerence was noted in MACE when comparing the revascularisation-performed group with a deferred
group.
Conclusion: Revascularisation guided by invasive physiological assessment with FFR or iFR is clinically safe and led to better
resource utilisation.
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INTRODUCTION
Coronary artery disease (CAD) has emerged as the most
common cause of death in low-middle income countries,
including Pakistan.1,2 Coronary angiography has been the gold
standard test to assess coronary stenosis; however, it explains
the location and severity of stenosis only anatomically.3 There is
also signiﬁcant inter-observer and intra-observer variability in
the reporting of stenoses. Recently introduced ancillary tests
like fractional ﬂow reserve (FFR) and instantaneous wave-free
ratio (iFR) are signiﬁcant tools for assessing the physiological
signiﬁcance of these stenosis.4,5 Physiological assessment of
anatomically intermediate-to-severe stenosis, using iFR and
FFR, has also been proven to reduce both the number of stents
used and major adverse cardiac events.6-8
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There is a higher prevalence of diabetes and multiple vessel
coronary artery disease among the South-Asian population.9,10
Most of the studies on the use and outcomes of FFR/iFR have
been conducted on the European/North American population.
Consequently, there is a paucity of data on the utilisation and
outcomes of FFR and iFR in the South-Asian population.11

METHODOLOGY
A longitudinal descriptive study was conducted from January
2012 to January 2020 in a cohort of patients with moderate to
severe coronary stenosis at The Aga Khan University Hospital,
Karachi. Patients in whom follow-up was not available and those
who refused to undergo revascularisation after positive physiological assessment, were excluded. A ﬁnal sample of 499
patients was included in the study. Data was collected retrospectively from the medical records of all the patients with intermediate-to-severe stenosis; and FFR or iFR was measured for the
assessment of hemodynamic signiﬁcance during the said
period. Patients aged >18 years, presenting with moderate-to-severe stenosis on visual estimation of the coronary angiogram
and a non-culprit vessel in patients presenting with the acute
coronary syndrome were included. For patients with an FFR
value of >0.80 and iFR value of >0.89, revascularisation was
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deferred, while it was performed where the values of FFR and
iFR were ≤0.80 and ≤0.89, respectively. In case of dissociation
in the FFR and iFR values, revascularisation was decided based
upon the FFR cutoﬀ.
Demographics and clinical characteristics of patients were
assessed including comorbidities, medication history, previous
history of MI, PCI, CABG, atrial ﬁbrillation, and stroke. The authors
further noted the target artery along with mean FFR and mean
iFR. The total numbers of FFR and IFR were recorded throughout
the study period. Post-FFR procedures were documented. Information on the outcome was also collected for any event that
occurred after the procedure as a major adverse cardiac event
(MACE), including cardiac death, non-fatal myocardial infarction,
and target vessel revascularisation. For this purpose, cardiac
death was deﬁned as any death in which a cardiac cause could
not be excluded. Non-fatal myocardial infarction was deﬁned
according to the fourth universal deﬁnition of MI. Target vessel
revascularisation (TVR) was deﬁned as PCI or application of
bypass grafts for restenosis of the previously-done FFR vessel.
The study was commenced after approval was obtained from the
Ethical Review Committee of the Hospital.
For the calculation of FFR/iFR, the Verrata plus coronary pressure
guidewire (Philips Volcano, USA) 0.014 inch was inserted into the
target artery. To achieve hyperemia during FFR measurement,
continuous intravenous adenosine 140/mcg/Kg/minute was
administered through a large bore cannula for 3-4 minutes. iFR
was calculated using an automatic algorithm in the Philips
volcano console. The follow-up data of all the patients were
collected from clinic visits or telephonic interviews. The next of
kin were interviewed in the case of patients who died. The clinical
outcomes were compared with a median follow-up of 29 months.
Data was analysed using STATA software (version 14.2; StataCorp, College Station, TX). For descriptive analysis, mean and
standard deviation were calculated for quantitative variables,
while proportions were computed for qualitative variables. For
quantitative variables, an independent t-test was used to
compute the diﬀerence between the two groups after assessing
normality. For inferential analysis, the groups of patients were
compared for all their characteristics using the Pearson Chi-test
and Fisher's Exact test (for qualitative variables). Cox proportional hazard model building was done using a stepwise
approach, by assessing all the plausible interactions and considering a p-value <0.05 as statistically signiﬁcant. In multivariable
analysis with Cox proportional hazard regression, diabetes
endured in the parsimonious model. In the patient-level analyses, MACE, target vessel revascularisation, non-fatal MI, and
cardiovascular death were analysed with the association of negative and positive iFR, adjusted for other variables. Kaplan-Meier
curves of MACE, target vessel revascularisation, non-fatal MI and
cardiovascular death with negative and positive FFR or iFR were
compared with the log-rank test.

RESULTS
The mean age was 62.8 ± 10.80, and 71.9% of the patients were
males. Baseline characteristics of both the groups were similar,
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but for the prior history of revascularisations as, shown in Table I.

The utilisation of invasive physiological assessment was <10%.
The most common indication for physiological assessment was
non-culprit artery stenosis in acute coronary syndrome (44.7%,
n=223). Twenty-two percent of the patients had moderate-to-severe LV dysfunction (ejection fraction ≤45).
The coronary angiogram indicated multivessel disease in
70.1% (n=350) of the cases. The most assessed artery was LAD
(61.3%), followed by RCA (19%, Table I). Of the patients with
angiographically severe stenosis, and who would have undergone revascularisation, the procedure was deferred in 43%
(Figure 1).

Figure 1: Change in decision based on invasive physiological
assessment.

Among patients having angiographically moderate stenosis,
thus not indicated for revascularisation, 14% proceeded for
revascularisation based on physiological severity (Figure 1).
Revascularisation of the assessed artery was performed percutaneously in 85% and surgically in 15% of the FFR/iFR- positive
group of patients. On multivariate regression analysis,
diabetes (HR=2.80, 95% C.I: 1.32-5.94, p=0.007) was an independent predictor of adverse outcomes.
The Kaplan-Meir method did not indicate a statistically signiﬁcant diﬀerence of MACE between the revascularisation-deferred
group (6.4% n=22) and revascularisation-performed group
(8.4% n=13), as shown in Figure 2. The Kaplan-Meier curves are
shown for the comparison of MACE, target vessel revascularisation, non-fatal MI, and cardiovascular death (Figure 2).

DISCUSSION
In this study, the decision of revascularisation was changed,
based on physiological assessment in approximately a quarter
of the cases.
In the present study, MACE rates were similar on event-free
survival in both the revascularisation-performed and the revascularisation-deferred groups, as shown in Figure 1.
As proved in previous literature, the decision making
regarding coronary intervention can be misguided by visual
3
angiographic estimation of coronary lesions.
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Table I: Baseline and procedural characteristics of patients of study population.

62.8± 10.80
359(71.9%)
379(76%)
251(50.3%)
263(52.7%)
86(17.2%)
27(5.4%)
39(7.8%)
55(11%)
12(2.4%)
18(3.6%)
86(17.2%)
14(2.8%)

Revascularisation
deferred group
n=345(69%)
62.6± 11.05
245(71%)
263(76.2%)
169(49%)
185(53.6%)
60(17.4%)
19(5.5%)
23(6.7%)
43(12.5%)
12(3.5%)
12(3.5%)
67(19.4%)
12(3.5%)

Revascularisation
performed group
n=154(31%)
63.2±10.23
114(74%)
116(75.3%)
82(53.2%)
78(50.6%)
26(16.9%)
8(5.2%)
16(10.4%)
12(7.8%)
0
6(3.9%)
19(12.3%)
2(1.3%)

223(44.7%)
3(1%)
67(23.2%)
204(70.6%)
15(5.2%)

151(43.8%)
3(1.5%)
58(29%)
135(67.5%)
4(2%)

72(46.8%)
0
9(10.1%)
69(77.5%)
11(12.4%)

0.536

492(98.6%)
375(75.2%)
494(99%)
410(82.2%)
99(19.8%)
200(40.1%)

338(98%)
233(67.5%)
340(98.6%)
273(79.1%)
74(21.4%)
137(39.7%)

154(100%)
142(92.2%)
154(100%)
137(89%)
25(16.2%)
63(40.9%)

0.106
<0.001
0.330
0.008
0.177
0.801

47(9.4%)
63(12.6%)

31(9%)
41(11.9%)
Revascularisation
deferred group
n=345(69%)

16(10.4%)
22(14.3%)
Revascularisation
performed group
n=154(31%)

260(75.4%)
85(24.6%)

43(27.9%)
111(72.1%)

<0.001

6(1.7%)
184(53.3%)
54(15.7%)
81(23.5%)
3(0.9%)
8(2.3%)
7(2.0%)
2(0.6%)

2(1.3%)
122(79.2%)
11(7.1%)
14(9.1%)
2(1.3%)
2(1.3%)
1(0.7%)
0

<0.001

0.88±.05
0.94±.03

0.75±.04
0.81±.07

<0.001
<0.001

0
161(46.7%)
4(1.2%)
0

84(54.5%)
0
24(15.6%)
46(29.9%)

<0.001

Baseline
characteristics

Total Cohort
n=499

Age (± SD years)
Gender (male)
HTN
Diabetes
Dyslipidemia
Smoker
COPD
CKD
Prior MI
Prior CABG
Prior Stroke
Prior PCI
History of atrial ﬁbrillation

Indication for procedure
ACS
CCS I
CCS II
CCS III
CCS IV
Discharge medications
Aspirin
Clopidogrel
Statin
Beta blocker
Calcium channel blocker
ACE inhibitors/ARBs
Ejection fraction
EF<30%
EF 30-45%

Angiographic ﬁndings and revascularisation
Disease severity on visual angiographic assessment
Moderate stenosis (50-69%)
Severe stenosis (>70%)
Target artery
LM
LAD
LCX
RCA
Diagonal
OM
Ramus
RPDA
FFR/iFR value
Mean FFR
Mean iFR
Post physiological assessment intervention
PCI only to FFR measured lesion
PCI only to FFR non-measured lesion
CABG
PCI to both FFR measured and non-measured artery

In this study, the change in the decision regarding revascularisation observed was 24.6%, similar to that reported by Ripcord
(26%) and Famous NSTEMI (21%). 12,13 However, in other
studies such as the Pressure-wire study (34%) and POST-IT
(45%) study, the numbers are as high as 45 %.14,15 This emphasised that invasive physiological assessment can guide decision-making by crossing patients over to better suited therapeutic strategy.
The MACE rates in the three-year follow-up of FAME 2 trials
were 10.1% in the PCI+MT group (FFR positive + PCI group),
similar to this study with MACE rate of 8.4%.16 In the COFFRS
study from India, the revascularisation group had MACE rate of
2.28% at 18 months follow-up.17 This diﬀerence in outcomes

p-value
0.589
0.489
0.827
0.379
0.539
0.890
0.887
0.152
0.124
0.022
0.817
0.053
0.244

<0.001

0.635
p-value

compared to COFFRS can be explained by the older age group
(mean age 62.8 vs. 56.3 years), longer follow-up period (29
months vs. 18 months), and the relatively higher number of
ACS patients (44.7% vs. 14%) in the present cohort.17
The physiological assessment-based treatment not only
minimises the number of unnecessary interventions, but also
leads to better allocation of limited resources in a low- to-middle-income country. This utilisation should be increased considering the pronounced economic and clinical beneﬁts of using
physiological assessment in decision-making. In the present
data on multivariate analysis, the independent predictor of a
MACE event was the presence of diabetes, consistent with the
data from prior studies.18,19
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Figure 2: Kaplan meir curve showing MACE, target vessel revascularisation, non-fatal MI, and cardiovascular death.

To the best of authors’ knowledge, this is the ﬁrst and
largest study on long-term outcomes of physiological assessment-based revascularisation from Pakistan. These results
follow trends in outcomes similar to studies from other countries. To generate a more robust local research data, a
prospective multicentre randomised study should be
performed.

ETHICAL APPROVAL:
Approval from Ethical Review Committee, The Aga Khan University Hospital Karachi, Pakistan taken before initiation of study
(ERC No. 2020-5089-11578).

This study has several limitations. First, it is a single-centre
retrospective observational study, and hence has limited
generalisability. Second, a longer follow-up is needed to validate the present results. Although the follow-up period was
indeed long, index case tracing and response from patients
were diﬃcult for cases enrolled in the earlier years of study
induction.
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CONCLUSION
Physiological assessment of coronary lesions led to a better
selection of patients for revascularisation. It prevented mislabelling of intermediate coronary stenoses and averted unnecessary interventions, in turn leading to a decrease in complications of procedures, and use of dual antiplatelets.
1266
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